Literature DB >> 34301495

Integrating diabetes technologies with team-based primary care for type 2 diabetes: A pilot trial.

Matthew J O'Brien1, John J Stephen2, Kristine L Norton3, Thomas P Meehan4, Deneen Vojta3, Ronald T Ackermann5.   

Abstract

This pilot trial studied a novel intervention that integrated diabetes technologies into team-based primary care for type 2 diabetes. We found clinically significant reductions in blood pressure, weight, and glucose. The latter two were statistically significant.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Diabetes management; Diabetes mellitus; Diabetes technology

Mesh：

Year:  2021        PMID： 34301495      PMCID： PMC9172266          DOI： 10.1016/j.pcd.2021.07.010

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN： 1878-0210            Impact factor:   2.567


  17 in total

1.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society.

Authors:  Michael D Jensen; Donna H Ryan; Caroline M Apovian; Jamy D Ard; Anthony G Comuzzie; Karen A Donato; Frank B Hu; Van S Hubbard; John M Jakicic; Robert F Kushner; Catherine M Loria; Barbara E Millen; Cathy A Nonas; F Xavier Pi-Sunyer; June Stevens; Victor J Stevens; Thomas A Wadden; Bruce M Wolfe; Susan Z Yanovski
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

2.  A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes.

Authors:  Antonio Nicolucci; Stefania Cercone; Alberto Chiriatti; Fabrizio Muscas; Gianfranco Gensini
Journal:  Diabetes Technol Ther       Date:  2015-07-08       Impact factor: 6.118

Review 3.  Do Mobile Phone Applications Improve Glycemic Control (HbA1c) in the Self-management of Diabetes? A Systematic Review, Meta-analysis, and GRADE of 14 Randomized Trials.

Authors:  Can Hou; Ben Carter; Jonathan Hewitt; Trevor Francisa; Sharon Mayor
Journal:  Diabetes Care       Date:  2016-11       Impact factor: 19.112

4.  Diabetes Technology: Review of the 2019 American Diabetes Association Standards of Medical Care in Diabetes.

Authors:  James J Chamberlain; Kacie Doyle-Delgado; Lacie Peterson; Neil Skolnik
Journal:  Ann Intern Med       Date:  2019-08-13       Impact factor: 25.391

5.  A Ubiquitous Chronic Disease Care system using cellular phones and the internet.

Authors:  H J Yoo; M S Park; T N Kim; S J Yang; G J Cho; T G Hwang; S H Baik; D S Choi; G H Park; K M Choi
Journal:  Diabet Med       Date:  2009-06       Impact factor: 4.359

6.  Telemonitoring and Team-Based Management of Glycemic Control on People with Type 2 Diabetes: a Cluster-Randomized Controlled Trial.

Authors:  Jun Yang Lee; Carina Ka Yee Chan; Siew Siang Chua; Chirk Jenn Ng; Thomas Paraidathathu; Kenneth Kwing Chin Lee; Shaun Wen Huey Lee
Journal:  J Gen Intern Med       Date:  2019-09-11       Impact factor: 5.128

7.  Blood pressure variability: clinical relevance and application.

Authors:  Gianfranco Parati; George S Stergiou; Eamon Dolan; Grzegorz Bilo
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07       Impact factor: 3.738

8.  Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.

Authors:  Kamlesh Khunti; Michael L Wolden; Brian Larsen Thorsted; Marc Andersen; Melanie J Davies
Journal:  Diabetes Care       Date:  2013-07-22       Impact factor: 19.112

9.  Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial.

Authors:  Sarah H Wild; Janet Hanley; Stephanie C Lewis; John A McKnight; Lucy B McCloughan; Paul L Padfield; Richard A Parker; Mary Paterson; Hilary Pinnock; Aziz Sheikh; Brian McKinstry
Journal:  PLoS Med       Date:  2016-07-26       Impact factor: 11.069

Review 10.  Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review.

Authors:  Jennifer Okemah; John Peng; Manuel Quiñones
Journal:  Adv Ther       Date:  2018-10-29       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.